N Blanca-Lopez
Overview
Explore the profile of N Blanca-Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
875
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haroun-Diaz E, Vazquez de la Torre M, Somoza M, Blanca-Lopez N, Martin-Pedraza L, Prieto-Moreno A, et al.
J Investig Allergol Clin Immunol
. 2022 May;
33(2):147-148.
PMID: 35588194
No abstract available.
2.
Haroun Diaz E, Martin-Pedraza L, Betancor D, Somoza M, Blanca-Lopez N, Vazquez de la Torre M, et al.
J Investig Allergol Clin Immunol
. 2022 Mar;
33(1):45-47.
PMID: 35234640
No abstract available.
3.
Haroun-Diaz E, Blanca-Lopez N, Martin-Pedraza L, Ruano F, Somoza M, Vazquez de la Torre M, et al.
J Investig Allergol Clin Immunol
. 2021 Sep;
32(1):50-52.
PMID: 34515030
No abstract available.
4.
Haroun-Diaz E, Torres Rojas I, Blanca-Lopez N, Somoza Alvarez M, Martin-Pedraza L, Ruano F, et al.
J Investig Allergol Clin Immunol
. 2021 Jun;
32(2):150-152.
PMID: 34085937
No abstract available.
5.
Audicana M, Ortega N, Lobera T, Blanca-Lopez N, De la Parte B, Garcia I, et al.
J Investig Allergol Clin Immunol
. 2021 Mar;
31(5):385-403.
PMID: 33653682
The controlled drug provocation test (DPT) is currently considered the gold standard for the diagnosis of drug allergy. Adverse drug reactions (ADRs) are an increasingly common presenting complaint in both...
6.
Dona I, Blanca-Lopez N, Boteanu C, Cueva-Oliver B, Fernandez-Sanchez F, Gajate P, et al.
J Investig Allergol Clin Immunol
. 2021 Jan;
31(4):292-307.
PMID: 33461956
The consumption of quinolones as first-line treatment has increased in recent years, leading to an increase in the incidence of hypersensitivity reactions (HSRs) to this antibiotic group. Both diagnosis and...
7.
Vazquez de la Torre M, Haroun-Diaz E, Blanca-Lopez N, Somoza M, Ruano F, Garcimartin M, et al.
J Investig Allergol Clin Immunol
. 2020 Oct;
30(5):360-362.
PMID: 33021472
No abstract available.
8.
Cabanas R, Ramirez E, Sendagorta E, Alamar R, Barranco R, Blanca-Lopez N, et al.
J Investig Allergol Clin Immunol
. 2020 Jan;
30(4):229-253.
PMID: 31932268
Background And Objective: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a complex multisystemic severe drug hypersensitivity reaction whose diagnosis and management are troublesome. DRESS syndrome requires management...
9.
Gomez E, Ruano M, Somoza M, Fernandez J, Blanca-Lopez N
Curr Opin Allergy Clin Immunol
. 2019 May;
19(4):294-301.
PMID: 31135394
Purpose Of Review: Nonimmediate drug hypersensitivity reactions (NI-DHR) constitute the most complex group of drug allergy, with many drugs involved. Both parent drugs and their reactive metabolites can be implicated....
10.
Rondon C, Blanca-Lopez N, Campo P, Mayorga C, Jurado-Escobar R, Torres M, et al.
Allergy
. 2017 Nov;
73(4):905-915.
PMID: 29168570
Background: Allergen immunotherapy has been shown to be an effective treatment for local allergic rhinitis (LAR) to house dust mites. Studies with pollen allergen immunotherapy are limited to observational studies....